BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathwayXiaoxing Li, Qifeng Yang|Cell Death and Disease|2013Cited by 24
1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trialHui‐Chuan Sun, Xiao‐Dong Zhu, Feixia Shen et al.|Annals of Oncology|2025Cited by 3